← Open Payments lookup

MARCELLUS CEPHAS: Open Payments

NPI 1134116007 · WHITESBORO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$736 in 38 payments from 11 companies in 2025. Trend: 2023 $566 · 2024 $418 · 2025 $736

Food & beverage: $624Education: $111
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.11$244
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$181
Alkermes, Inc.4$72
Neurocrine BioSciences, Inc.3$60
Lundbeck LLC2$45
Janssen Pharmaceuticals, Inc1$37
Indivior Inc.1$21
Axsome Therapeutics, Inc.1$21
ABBVIE INC.1$20
Vanda Pharmaceuticals Inc.1$19

Products named: CAPLYTA, UZEDY, ARISTADA, INGREZZA, REXULTI, AUSTEDO XR, INVEGA SUSTENNA, SUBLOCADE.

Industry payments across NY — which companies pay providers there.